SCHEMBL9529016

SCHEMBL9529016

CCCCc1c(CF)n(C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.47
AGTR2 P50052 9/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9536768 0.96 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9531696 0.93 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9554008 0.90 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9554571 0.90 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9531360 0.90 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9529829 0.90 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9553796 0.90 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9035428 0.89 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9531954 0.89 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9530098 0.89 AGTR1 (0.46) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed